by Admin | May 3, 2020 | Adjuvants, Adverse Events, Aluminum, Neurological Disorders, Vaccine Ingredients, Vaccines
“These current data implicate Al injected in early postnatal life in some CNS alterations that may be relevant for a better understanding of the aetiology of ASD.”
PubMed
by Admin | May 3, 2020 | Adjuvants, Adverse Events, Aluminum, Autism, Neurological Disorders, Vaccine Ingredients, Vaccines
“Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades (Pearson r=0.92, p<0.0001); and (iii) a significant correlation exists between the amounts of Al administered to preschool children and the current prevalence of ASD in seven Western countries, particularly at 3-4 months of age (Pearson r=0.89-0.94, p=0.0018-0.0248). The application of the Hill’s criteria to these data indicates that the correlation between Al in vaccines and ASD may be causal.”
PubMed
by Admin | Apr 30, 2020 | Adverse Events, Aluminum, Autism, Vaccine Ingredients
“A correlation between increasing ASD rates and aluminium (Al) adjuvants in common use in paediatric vaccines in several Western countries. The correlation between ASD rate and Al adjuvant amounts appears to be dose-dependent.”
Journal of Inorganic Biochemistry, 2013
by Admin | Apr 30, 2020 | Adverse Events, Allergies, Aluminum, Autism, Gastrointestinal, Mercury, Vaccine Ingredients
“A careful review of ASD cases discloses a number of events that adhere to an immunoexcitotoxic mechanism. This mechanism explains the link between excessive vaccination, use of aluminum and ethylmercury as vaccine adjuvants, food allergies, gut dysbiosis, and abnormal formation of the developing brain.”
PudMed – Alternative Therapies in Health and Medicine